TY  - JOUR

T1  - A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales

JO  - Value in Health

PY  - -0001/11/30

AU  - Rafia R

AU  - Metry A

AU  - Wailoo A

ED  - 

PB  - Elsevier

Y2  - 2024/12/22

ER  -